What You Can Learn From Bioxyne Limited’s (ASX:BXN) P/S After Its 31% Share Price Crash
Bioxyne Limited (ASX:BXN) shares have retraced a considerable 31% in the last month, reversing a fair amount of their solid recent performance. Of course, over the longer-term many would still wish they owned shares as the stock’s price has soared 192% in the last twelve months.
In spite of the heavy fall in price, you could still be forgiven for thinking Bioxyne is a stock not worth researching with a price-to-sales ratios (or “P/S”) of 2.7x, considering almost half the companies in Australia’s Personal Products industry have P/S ratios below 1x. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the elevated P/S.
This technology could replace computers: discover the 20 stocks are…
